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Abstract 
 
An overwhelming number of women report sleep difficulties in midlife. The purpose of the 
present research was to identify possible factors contributing to this. Menopausal status, 
vasomotor symptoms, psychological health, health behaviours and demographic 
characteristics were examined as predictors of sleep quality. A total of 292 women aged 
40-60 years (M=51.01) completed an online questionnaire assessing: sleep quality 
(Pittsburgh Sleep Quality Index), menopausal status, vasomotor symptoms (Greene 
Climacteric Scale), depression (Patient Health Questionnaire-9), anxiety (General Anxiety 
Disorder Assessment-7), alcohol consumption, smoking status, physical activity level and 
demographic information. Results revealed that 80.3% of women were poor sleepers. A 
multiple regression analysis identified that vasomotor symptoms, anxiety and depression 
were unique predictors of poor sleep quality. Depression was found to make the largest 
contribution. Overall, findings propose specific factors which may play a significant role in 
the sleep difficulties reported by midlife women. In consideration of these findings, 
promising implications for future research and interventions are discussed. 
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Introduction 
 
Women report finding new energy and enthusiasm for life during middle age 
(Dennerstein, Lehert, & Guthrie, 2002). Yet paradoxically, such women are twice as 
likely to report sleep problems compared to younger equivalents (Minarik, 2009). 
Prevalence studies show around 40-60% of women aged 40-65 years report frequent 
sleep complaints (Ağan et al., 2015; Lampio, Saaresranta, Engblom, Polo, & Polo-
Kantalo, 2016; Kravitz et al., 2003; Kravitz et al., 2008; Xu, Zhao, Chen, & Jing, 2016). 
Of these women, 30% report their sleep problems to be severe and have substantial 
effects on their daily lives (Polo-Kantolo, 2011; Baker, De Zambotti, Colrain & Bei, 
2018). Typically, midlife women report having significant troubles initiating sleep, 
awakening throughout the night, waking up early and feeling unrefreshed (National 
Sleep Foundation [NSF], 2002). National studies have found such sleep difficulties 
occur more than 3-times per week (NSF, 2007; Kravitz et al., 2008). Disturbingly, 
troubles are found to persist for 3 years on average (Tom, Kuh, Guralnik & Mishra, 
2010) and this is not without detrimental consequence. Insufficient or inefficient sleep 
has been associated with copious adverse outcomes. Common impairments include 
cognitive decline (Roth & Ancoli-Israel, 1999), occupational dysfunction (NSF,2007), 
poor interpersonal relationships (Chasens, Twerski, Yang & Umlaug, 2010), 
susceptibility to disease (Foley, Ancoli-Israel, Britz & Walsh, 2004), poorer quality of 
life (Bolge, Balakrishnan, Kannan, Seal & Drake, 2010), and most worryingly, early 
mortality (Cappuccio, D’Elia, Strazzulo & Miller, 2010). Midlife women have specifically 
reported being involved in car crashes and near fatal accidents due to driving whilst 
feeling tired (NSF, 2007). Given the global aging population, women spend a greater 
proportion of their lives in midlife than in previous generations (Lahdenperä, Lummaa, 
Helle, Tremblay & Russell, 2004). Thus, they are at greater risk of the aforementioned 
consequences caused by sleep disruption. In order for health professionals to be able 
to reduce such risks, the aetiology of sleep disruption for midlife women must be 
understood.  
 
Midlife coincides with the menopause, and sleep is negatively affected during the 
menopause transition. Menopause or ‘perimenopause’ is defined as the cessation of 
menstruation (National Institute for Health and Care Excellence [NICE], 2015), 
preceded by ‘premenopause’, whereby menstruation remains regular; and followed by 
the ‘postmenopause’, whereby menstruation has ceased for 12 months (The Stages 
of Reproductive Aging Workshop [STRAW]- Harlow et al., 2012). Subjective sleep 
studies have established that women’s sleep complaints increase across the 
menopausal transition. Perimenopausal and postmenopausal women are consistently 
found to have greater prevalence of sleep difficulties than premenopausal women 
(Shaver, Giblin & Paulsen, 1991; Kuh, Wadsworth & Hardy, 1997; Owens & Matthews, 
1998; Chung & Tang, 2006; Tom et al., 2010; Freeman, Sammel, Gross & Pien, 2015). 
In a study of 12,600 women, Kravitz et al. (2003) found approximately 50% of 
perimenopausal and postmenopausal women had sleeping difficulties, relative to 30% 
of premenopausal women. More recently, Xu and Lang (2014) conducted a meta-
analysis reviewing 24 studies (n=63,500), concluding that women in perimenopause 
and postmenopause have a 2-fold risk of experiencing sleep problems compared to 
premenopause. Incidence of specific sleep complaints are also associated with the 
menopause. For example, in a 5-year longitudinal study, Lampio et al. (2017) found 
that relative to premenopausal women, menopausal (perimenopausal and 
postmenopausal) women were more likely to experience sleep difficulties such as; 
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‘difficulty falling asleep’ (11% vs 43%) and ‘nocturnal awakenings’ (26% vs 55%). 
Although overwhelming evidence suggests that women self-report poorer sleep within 
the menopause (Baker, Simpson & Dawson, 1997; Barnabei et al, 2002; NSF, 2007; 
Cheng et al., 2008; Berecki-Gisolf, Begum & Dobson, 2009; Woods & Mitchell, 2010), 
not all studies report such an association (Pien, Sammel, Freeman, Lin & DeBlasis, 
2008; Blümel et al., 2012). This highlights that menopause may not invariably have a 
negative effect on sleep quality. Typically, authors conclude that specific symptoms 
associated with the menopause have greater influence upon sleep difficulties than the 
menopause transition itself (Xu et al., 2016).  
 
One core symptom of menopause, vasomotor symptoms (VMS); comprises of night 
sweats and hot flushes. Women with symptoms experience an intense and transient 
sensation of heat during sleep and awaken to find themselves covered in perspiration 
(NIH, 2005; Ameratunga, Goldin & Hickey, 2012). Unsurprisingly, research 
demonstrates that symptomatic women report poorer sleep quality than their 
asymptomatic equivalents (Chasens et al., 2010; Ohayon, 2006; Pien et al., 2008). 
Kravitz et al. (2003) found that sleep problems were 2-times greater in those 
experiencing VMS relative to those who were not. Subsequent research into 3000 
midlife women (Kravitz et al., 2008), reported odd ratios (OR) were significantly higher 
for women with severe VMS (>6 days in a 2-week period) than no symptoms on 3 
sleep difficulties; trouble falling asleep (5.3 vs 1.9), awakening during the night (4.9 vs 
1.7) and waking up early (3.9 vs 1.7). Similarly, Woods and Mitchell (2010) reported 
across their 17-year longitudinal study, that the frequency of hot flushes, alongside 
other symptomology (e.g. backache); were associated with problems going to sleep, 
severity of night time awakening and early morning awakenings. Studies using 
objectives measures also draw similar conclusions (Woodward & Freedman, 1994; 
Baker, Willoughby, Sassoon, Colrain & De Zambotti, 2015). Joffe et al. (2013) 
hormonally induced VMS in 29 healthy, premenopausal women (aged 18-45 years) 
with no history of sleep disturbance. Utilising Polysomnography (PSG) and self-report 
measures, they identified that VMS correlated directly with degree of sleep 
fragmentation. In critique, Thurston et al. (2008) proposed that research should 
consider the associated bother and interference of VMS, above the frequency or 
physiological presence of symptoms. Xu et al. (2012) reported only bothersome hot 
flushes, but not hot flushes alone, were associated with sleep disturbance (OR: 2.7 vs 
1.3). However, this is the only study to address this and there is need for further 
exploration into the perceived “bothersomeness” of VMS and sleep difficulty.  
 
Research exploring women’s perceptions of their symptoms is important because in 
addition to the physical effects of midlife, psychological symptoms are associated with 
sleep quality. Previous research has established that depressive complaints are often 
accompanied by severe sleep problems (Ford & Kamerow, 1989; McCall, Reboussin 
& Cohen, 2000). For example, Sivertson et al. (2012) found depressed individuals 
were twice as likely to report sleep difficulties as opposed to non-depressed (22% vs 
10%). Research into midlife women report similar findings. Bosworth et al. (2001) 
studied 581 women aged 45-55 years, concluding that sleep problems were 
significantly greater in depressed, compared to non-depressed women (61% vs 39%). 
Chung and Tang (2006) identified that relative to non-depressed women, depressed 
women had a 4-fold increased risk of reporting disturbed sleep. When analysing 
specific sleep quality variables, Joffe et al. (2009) found depressed midlife women 
took significantly longer to fall asleep and had a shorter total sleep time than their non-
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depressed equivalents. Lampio et al. (2014) added that depressive symptoms also 
increased nocturnal awakenings, and daytime tiredness within their midlife female 
sample. Similar effects on sleep have been found when individuals report having only 
mild psychological symptoms (Buysse et al., 2008). Thus, plentiful research highlights 
that depression and low mood has an impact on sleep within this cohort (Xu et al., 
2016; Tom et al., 2010). 
 
Like depression, anxiety correlates with poor sleep quality (Rawsawh, Stein, Belik, 
Jacobi & Sareen, 2009; Soehner & Harvey, 2012). Surprisingly, it has received much 
less attention in the studies of midlife women, despite being more strongly related to 
sleep problems than depression (OR: 3.35 vs 1.96 - Jansson & Linton, 2006). Thus 
far, research has understood that women with higher levels of anxiety report poorer 
sleep quality (Freedman & Roehrs, 2007). Xu et al. (2016) identified that symptomatic 
women were 3 times more likely to report sleep difficulties than asymptomatic women. 
A qualitative analysis by the NSF (2007), found that ‘worrying too much’ and/or ‘being 
stressed or anxious’ were the most common reasons for sleep difficulties. Around 80% 
of women reported such complaints. Cheng et al. (2008) identified that females with 
high anxiety typically exhibited troubles initiating and maintaining sleep. They also 
reported frequently using sleep medication to aid their troubles. Overall, there is very 
limited research addressing the association between anxiety and sleep in midlife 
women. However, a greater understanding is imperative. Midlife constitutes a 
‘vulnerable window’ for women - where they are 14-times more likely to develop 
psychological problems (Schmidt, Haq & Rubinow, 2004). Therefore, the impact on 
sleep, and its further consequences, could be detrimental if left unexplored.  
 
Moreover, health behaviour change is common in midlife, and unhealthy habits have 
been associated with sleep problems (Gold et al., 2000). Schoenborn and Adams 
(2008) highlighted that those engaging in health risk behaviours such as smoking, 
alcohol consumption and physical inactivity, reported less sleep duration compared to 
those whom did not (<6 hours vs 7-8 hours sleep per night). However, less is 
understood about the effect of such habits on sleep quality - particularly in midlife 
women. Thus far, female cigarette smokers, relative to non-smokers; are found to 
have greater sleep difficulties (31% vs 7% - Ağan et al., 2015). In a sample of 3,655 
women (aged 34-67 years), Soltani et al. (2012) found sleep quality decreased in 
proportion to the number of cigarettes smoked daily. Those smoking over 20 cigarettes 
per day were twice as likely to report poor sleep quality than non-smokers (14% vs 
7%). Similarly, midlife women whom report physical inactivity are twice as likely to 
exhibit sleep problems than women who are active (Gold et al., 2000). The NSF (2013) 
compared a large sample (n=1000) of male and female (aged 23-60 years) vigorous, 
moderate, light and non-exercisers. Reports of good sleep quality reduced from 83%, 
77%, 76% to 56% respectively. Conversely, in other studies, greater physical exertion 
has been found to promote sleep troubles. Trinkoff, Storr, & Lipscomb (2001) found 
physically demanding occupations, such as nursing; were associated with self-
reported inadequate sleep. Mixed results are also documented for the relationship 
between alcohol consumption and sleep quality. Controversially, some studies show 
that alcohol has a beneficial, sedative effect on sleep. For example, Soltani et al. 
(2012) found women drinking 1-2 glasses of alcohol per day more frequently reported 
no sleep problems than those who abstained (69% vs 63%). However, research also 
suggests that high consumption may have a negative, stimulating effect on sleep. 
Women whom drank more than 2 glasses of alcohol per day were found to have 
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marginally poorer sleep quality than those who drank 1 (8% vs 6%) (Soltani et al., 
2012). Woods and Mitchell (2010) found that increased alcohol consumption was 
associated with both night time awakenings and shorter sleep onset in midlife women, 
providing evidence of both stimulating and sedative effects of alcohol on sleep. 
Overall, research addressing an association between health behaviours and sleep 
quality in midlife women is very limited. Yet further exploration is due, as risk 
behaviours are significantly greater within this stage of life (Office for National 
Statistics [ONS], 2018) thus, placing midlife women in greater likelihood of sleep 
deficiencies.  
 
Overall, the aforementioned literature clarifies the complex and multifactorial 
aetiologies of sleep disturbance in midlife women. In reflection of this, the present 
research examined the relative importance of menopausal status, VMS, psychological 
health (depression and anxiety) and health behaviours (cigarette smoking, physical 
activity and alcohol consumption) on predicting sleep quality in midlife women. The 
following study extended previous research by examining the effect of bothersome 
VMS, anxiety symptoms and health behaviours, all of which have been neglected 
within previous research regarding midlife women; and warrant further understanding. 
The purpose of this study was to explore the relationship between menopausal status, 
VMS, psychological health, health behaviours and sleep quality. Additionally, to 
identify if the variables aforementioned could collectively and independently predict 
sleep quality, and if so, which variable predicts sleep quality the greatest. To the 
authors knowledge, this research is the first to explore such variables together, thus 
no specific predictions were made. Findings will provide greater understanding as to 
what may be influencing the poor sleep quality consistently reported by midlife women. 
To reiterate, poor sleep quality can have detrimental effects on health and functioning. 
Therefore, it is important for researchers and clinicians to gain greater understanding 
as to what factors may contribute to midlife women’s sleep quality in order to be able 
to formulate treatment strategies, or even preventative measures.  
 
 
Method 
 
Participants 
 
The inclusion criteria of this study were (1) female, (2) aged 40-60 years. This age 
bracket was decided as women are highly symptomatic around these ages (Harlow et 
al., 2017), and previous research examines this age group (Blümel et al., 2012). 
Exclusion criteria included women who had (1) undergone hysterectomy surgery or 
(2) utilised contraception and not had a regular menstrual cycle within the past 3 
months. This was enforced so women could report their menopausal status, as 
hysterectomy surgery and contraception can artificially decrease regularity or stop 
menstruation completely. 
 
This study’s final sample comprised of 292 women aged 40-60 years old (M=51.01, 
SD=5.07). Although 428 participants gave consent, 83 responses were excluded due 
to questionnaire incompletion and 53 responses were excluded due to participants 
meeting exclusion criteria.  
 
Procedure 
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Following approval from Oxford Brookes University Psychology Ethics Committee, 
questionnaires were distributed from the 20th of December 2018 until the 5th of 
February 2019. Participants were recruited online, through advertisement on the 
researchers personal Facebook, and an inclusive women’s Facebook group (“UK 
Ladies Menopause Support Group”), of which the researcher gained permission to 
access. A snowball sampling technique was also adopted, as participants were 
encouraged to distribute the questionnaire link via their own Facebook. Those whom 
participated were presented with the participant information sheet (PIS); a brief 
description outlining the purpose and procedures of the research, and participants’ 
right to withdraw. Those consenting to participate were assured that their anonymity 
would be preserved, as no IP addresses were collected, and data was both encrypted 
and password protected.  In adherence to the British Psychological Society (BPS) 
guidelines, the PIS was piloted on an individual who satisfied inclusion criteria 
(Female, aged 53) to ensure suitability and readability of the language for the sample 
population. 
 
Measures 
 
An online questionnaire was designed and presented to participants on Qualtrics. Its 
completion time was approximately 15 minutes.  The main questionnaire consisted of 
6 sections assessing; sleep quality, menopausal status, VMS, psychological health, 
health behaviours and demographic information. Before this could be completed, 
participants completed a section regarding their eligibility to participate. 
 
Section 1: Exclusion questionnaire.  
 
Eligibility was established using 3 dichotomous questions. Participants were excluded 
from the study if they answered ‘yes’ to having undergone hysterectomy surgery, 
and/or utilising 1 of the 4 contraception methods (e.g. “contraception implant”), and 
‘no’ to having vaginal bleeding within the last 3 months. However, those answering 
‘yes’ to utilising contraception and ‘yes’ to having vaginal bleeding within the past 3 
months were included. Likewise, those responding ‘no’ to hysterectomy surgery were 
included and taken to the next section. This section was created to enforce exclusion 
criteria that may have been overlooked in the PIS. 
 
Section 2: Sleep quality: Pittsburgh Sleep Quality Index (PSQI). 
 
The PSQI (Buysse, Reynolds, Monk, Berman & Kupfer, 1989) comprises of 19-items 
that measure participants sleep quality over a 1-month period. The first 4 questions 
are open-ended and require participants to report their time-related sleep habits (e.g. 
“How long [in minutes] has it usually taken for you to fall asleep each night?”).  The 
remaining 6 questions require participants to answer on a 4-point scale. Firstly, how 
often they have experienced sleeplessness symptoms during the past month (e.g. 
“cannot get to sleep within 30 minutes” - 0= ‘Not during the past month’ to 3= ‘Three 
of more times a week’). Secondly, how they rate their sleep (“How would you rate your 
sleep quality overall?” - 0= ‘Very good’ to 3= ‘Very Bad’), and thirdly, how much of a 
problem daytime dysfunction has been (e.g. “enthusiasm to get things done” - 0= ‘No 
problem at all’ to 3= ‘A very big problem’). Question 10 concerning bed partners was 
omitted from the present questionnaire, due to its exclusion from published scoring.  
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Items yield 7 component scores; subjective sleep quality, sleep latency, sleep 
duration, habitual sleep efficiency, sleep disturbances, use of sleep medications and 
daytime dysfunction. Each scored 0-3. Components are then summed to create a 
Global PSQI score, ranging from 0-21. A higher score signifies worse sleep quality.  A 
PSQI score of 5 or greater defines the participant as a “Poor” sleeper. This cut off point 
is shown to have diagnostic sensitivity and specificity of around 90% (Buysse et al., 
1989). The instrument was found to have high internal consistency (9 items, α= 0.78).  
 
Section 3: Menopausal status.  
 
Three definitions were presented describing different frequencies and regularities of 
vaginal bleeding. Participants were required to select one definition that best 
described their vaginal bleeding pattern. Women reporting “I have experienced normal 
bleeding in the past 3-months, and it has been regular over the past year” were 
categorised as “premenopausal”; those reporting “I have experienced bleeding within 
the past 12-months, but it has decreased in regularity over the past year” were defined 
as “perimenopausal”; and women answering “I have experienced no bleeding within 
the past 12-months” were considered to be “postmenopausal”. Definitions utilised in 
this section were based upon the recommended staging system of STRAW (Harlow 
et al.,2012). 
 
Section 4: VMS severity: Greene Climacteric Scale (GCS). 
 
The GCS (Greene, 1998) comprises of 21-items that divide into 4 domains measuring 
the severity of menopausal symptoms. For the present questionnaire, only the domain 
of interest (VMS) consisting of 2-items was utilised. Participants were required to 
indicate on a 4-point scale the extent to which the symptoms (“Hot flushes” and 
“Sweating at night”) had bothered them within the past month (0= ‘Not at all’ to 3= 
‘Extremely’). Scores were summed to create a Vasomotor severity score, ranging from 
0-6. Higher scores reflect greater symptom severity. Normative data reported by 
Greene (1991) used a similar sample (200 Scottish women, aged 40-55 years), and 
found a mean score of 1.79 within the general population sample, compared to 4.41 
in the menopause clinic sample. This scale was found to have good internal 
consistency (2- items, α= .76). 
 
Section 5: Psychological health. 
 
Depression: Patient Health Questionnaire- 9 (PHQ-9). 
 
The PHQ-9 (Kroenke, Spitzer & Williams, 2001) consists of 10-items measuring 
depression severity over a 2-week period. The first 9-items present statements that 
relate to potential depressive symptoms (e.g. “Little interest or pleasure in doing 
things”). Participants are required to state on a 4-point scale how many days they have 
experienced each symptom (0= ’Not at all’ to 3= ‘Nearly every day’).  Question 10 
regarding difficulties in everyday life was discounted from the present questionnaire, 
due to its exclusion from the scoring. The first 9-item scores were summed to create 
the PHQ-9 score, ranging from 0-27. Higher scores reflected greater depression 
severity. PHQ-9 scores of 5, 10, 15 and 20 represented cut-off points for “mild”, 
“moderate”, “moderately severe”, and “severe” depression groups respectively. This 
instrument demonstrated good internal consistency (9-items, α = .89) 
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Anxiety: General Anxiety Disorder Assessment- 7 (GAD-7). 
 
The GAD-7 (Spitzer, Kroenke, Williams & Löwe, 2006) consists of 7-items which 
measure anxiety severity over a 2-week period. Participants were presented with 
statements relating to anxiety symptoms (e.g. “Feeling nervous, anxious or on edge”) 
and asked to report on a 4-point scale how many days such symptoms had been 
bothersome (0 = ‘Not at all’ to 3 = Nearly every day’). All scores were summed to 
create a GAD-7 score, ranging from 0-21. Higher scores reflected greater anxiety 
severity. Cut-off points of 5, 10, and 15 represented “mild”, “moderate” and “severe” 
levels of anxiety. The scale was found to have excellent internal consistency (7-items, 
α= 0.92). 
 
Section 6: Health behaviours. 
 
Alcohol consumption. 
 
A single-item assessed participants’ alcohol intake on a typical week. Participants 
were asked to place themselves in 1 of 4 groupings that best reflected their weekly 
unit intake. A unit guide from the AUDIT-C was presented to participants to aid their 
estimations. Responses of ‘0 units’, ‘0.5-7 units’, ‘7.5-14 units’ or ‘Over 14 units’ 
corresponded to coding’s of “abstainer”, “light drinker”, “moderate drinker” or “heavy 
drinker” respectively. This scale was based upon the UK government’s guidelines that 
recommends adults consume no more than 14-units of alcohol per week, to keep 
alcohol-related health risks low (Department of Health, 2016). 
  
Cigarette smoking status. 
 
Smoking status was assessed on whether participants had smoked a cigarette within 
the past month. Those reporting ‘no’ to smoking were coded as “non-smokers”. Those 
reporting ‘yes’ to smoking were required to select 1 of 4 coding’s that reflected the 
frequency of their smoking: “light daily smoker (1-5 cigarettes per day)”, “moderate 
daily smoker (6-10 cigarettes per day)”, “heavy daily smoker (11 or more cigarettes 
per day)” or “social smoker (usually only smoke with friends or on a night out)”. 
Criterion for each category was defined using Husten’s (2009) review of smoking 
status definitions across research. 
 
Physical activity level.  
 
Three statements were presented describing different physical activity levels (“Low”, 
“Moderate” or “High” physical activity). Each statement included examples of different 
activities at each intensity level, such as; exercise/sports, household/garden chores, 
occupation activities, and the amount of time approximately spent exercising per 
week. Statements were devised by the researcher based on the definitions of physical 
activity levels provided in literature (Bandmann, 2008; Scholes & Mindell, 2013; NHS, 
2018). Participants were required to select the statement describing their physical 
activity level within a typical week.  
 
Sections 7: Demographics 
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This section collected participants personal information such as their age, marital 
status, bed partner status, whether they had children and if so, whether their children 
lived at home.  
 
The questionnaire concluded with contact information and website links to guide 
participants who wanted further help and support.  
 
 
Results 
 
Before analysis commenced, the raw data was checked for missing values (i.e. items 
left blank). If approximately 80% of a scale was missing values, participants’ data were 
excluded for that scale. For example, a participant answered 2/9 PHQ-9 items (78% 
of data missing), resulting in exclusion from PHQ-9 analyses. Alternatively, when 
participants had the majority of their data, missing values were added by the 
researcher. This was only required for the PSQI on Likert scale items. Participants 
with missing values were assigned a 0 in assumption that the item in question did not 
occur. This was to avoid the loss of valuable data.  
 
In addition, variables were checked for normality. Inspection of histograms and 
normality plots showed data for global PSQI and VMS severity scores were normally 
distributed. However, PHQ-9 and GAD-7 scores deviated, displaying a positive skew. 
 
Exploration of sleep quality. 
 
Overall, the mean PSQI global score was 9.49 with a range of 0-20 (Table 1). This 
indicated that on average participants experience ‘poor sleep quality’ (Buysee et al., 
1989). Eighty- six percent of participants were poor sleepers (PSQI>5), compared to 
13.7% as good sleepers (PSQI ≤ 5) (Table 2).  
 
A frequency summary of the PSQI component scores can be seen in Table 3. Overall, 
43.2% of participants reported their sleep to be fairly bad, while 10.6% reported their 
sleep to be good. Thirty-eight percent of women took less than 15 minutes to fall 
asleep, and 12% took more than an hour. Fifty percent of participants had a total of 5-
6 hours of sleep every day, whilst 15.4% stated their sleep duration was over 7 hours 
per night. The mean hours of sleep were 6.11 (Table 1). Additionally, 30.8% had sleep 
efficiencies greater than 85%, but a similar percentage (26.7%) had sleep efficiencies 
less than 65%. The mean sleep efficiency was 76.14% (Table 1). In relation to sleep 
disturbance, the 4 most frequently cited events were “waking up in the middle of the 
night or early morning”, “getting up to use the bathroom”, “feeling too hot” and “cannot 
get to sleep within 30 minutes”.  The majority did not use sleep medication (78.4%) 
and did not have daytime dysfunction (68.2%). 
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Table 1 
Means and standard deviations of Global PSQI, sleep 
duration (in hours) and sleep efficiency (%) of participants 
(n=292) 
 
 M ± SD 
Global PSQI 9.49 ± 4.27 
Sleep Duration 6.11 ± 1.19 
Sleep Efficiency 76.14 ± 14.99 
Table 2 
Frequencies and percentages of good and poor sleepers 
(n=292) 
 
 N (%) 
Good Sleeper (PSQI ≤ 5) 40 (13.7) 
Poor Sleeper (PSQI > 5) 252 (86.3) 
Table 3.  
Frequencies and percentages for scores on each PSQI component and types of sleep 
disturbance reported (n= 292) 
 
 Score 
 0  1  2  3 
Component 
 
N %  N %  N %  N % 
Subjective Sleep Quality 31 10.6  103 35.5  126 43.2  32 11 
Sleep Latency 111 38  81 27.7  65 22.3  35 12 
Sleep Duration 45 15.4  76 26  146 50  25 8.5 
Sleep Efficiency  90 30.8  75 25.7  49 16.8  78 26.7 
Sleep Disturbance            
Cannot get to sleep within 30 minutes. 75 25.7  58 19.9  64 21.9  95 32.5 
Waking up in the middle of the night or 
early morning. 
19 6.5  38 9.6  53 18.2  192 65.8 
Getting up to use the bathroom. 31 10.6  48 16.4  53 18.2  160 54.8 
Not breathing comfortably. 221 75.7  31 10.6  20 6.8  20 6.8 
Coughing or snoring loudly 141 48.3  36 12.3  63 21.3  52 17.8 
Feeling too cold. 180 61.6  65 22.3  24 8.2  23 7.9 
Feeling too hot. 48 16.4  39 13.4  79 27.1  126 43.2 
Having bad dreams. 157 53.8  68 23.3  48 16.4  19 6.5 
Having pain. 138 47.3  51 17.5  45 15.4  58 19.9 
Use of Sleep Medication 229 78.4  17 5.8  18 6.2  28 9.6 
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Factors related to sleep quality. 
 
Firstly, analysis involved exploring predictor variables (demographics, menopausal 
status, VMS, psychological health and health behaviours), and looking for significant 
differences in these variables for those with poor and good sleep. Next, examining the 
strength of any associations between variables and overall sleep quality. Finally, a 
multiple regression was conducted to examine the predictive contribution, both 
collectively and independently, of all predictor variables on reported sleep quality. 
 
Demographic variables  
 
All of participants’ demographic characteristics are presented in Table 4. The mean 
age of the sample was 51.01 years (SD= 5.07), with a range of 40-60. Commonly, 
women reported having a bed partner (70.5%) and child(ren) living at home (57.9%). 
Only child status was found to significantly vary according to sleep quality status (X2 
(2, 292) = 8.75, p=.013, Cramer’s V=.17). The majority of both poor (55.6%) and good 
sleepers (72.5%) had children living at home. 
 
Menopausal status  
 
The majority of participants within the sample identified as ‘Postmenopausal’ (47.9%) 
(Table 4). The number of women with poor and good sleep quality varied significantly 
by menopausal status (X2 (2, 292) = 7.99, p=.018, Cramer’s V=.17). Higher 
percentages of poor sleepers were postmenopausal (50.4%) and perimenopausal 
(32.5%), compared to premenopausal (17.1%). The majority of good sleepers were 
premenopausal (35%). 
 
Vasomotor symptoms  
 
The mean total VMS severity score was 2.45 with a range of 0-6 (Table 4). Normative 
data previously identified a mean score of 1.79 within the general population, and 4.41 
in the menopausal clinic sample (Greene, 1991). This suggests the present sample 
displayed higher levels of bothersome symptoms than expected within the general 
population, but below clinical significance. Symptoms differed significantly between 
poor and good sleepers (t(290)=-9.17, p=<.001). Greater bothersome VMS were 
experienced by poor sleepers (M=2.69) than good sleepers (M=0.93). Scores were 
still not within a range considered to reach clinical significance. Additionally, 
participants were categorised into ‘Bothersome’ symptoms on the basis of reporting 
either ‘a little’, ‘quite a lot’ or ‘extremely’ bothersome VMS. ‘Not Bothersome’ reported 
‘not at all’ to experiencing symptoms. Compared to good sleepers, poor sleepers 
Daytime Dysfunction 199 68.2  45 15.4  38 13  10 3.4 
Note.  
For: 
Subjective Sleep Quality, “0” = very good, “1” = fairly good, “2” = fairly bad, “3” = very bad. 
Sleep Latency, 0” = <15 minutes, “1” = 16-30 minutes, “2” = 31-60 minutes, “3” = >60 minutes 
Sleep Duration, 0” = >7 hours, “1” = 6-7 hours, “2” =5-6 hours, “3” = < 5 hours. 
Sleep Efficiency, 0” = >85%, “1” = 75-84%, “2” = 65-74%, “3” = <65%. 
Sleep Disturbance & Use of Sleep Medication and Daytime Dysfunction: 0” = not during past month, “1” = less than once a 
week, “2” = once or twice a week, “3” = three or more times each week.  
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reported significantly greater bothersome (88.9% vs 55%) and less not bothersome 
symptoms (11.1% vs 45%) (X2 (1, 292) = 29.87, p<.001, phi=.32).   
 
Psychological Health 
 
The mean total score of the PHQ-9 was 8.66 with a range of 0-27 (Table 4). This 
indicated that on average participants experience ‘mild depression severity’ (Kroenke 
et al., 2001). A significant difference was found between depression scores for those 
with poor and good sleep quality (U=1265, p= <.001). On average, poor sleepers fell 
in the ‘moderate depression’ band (M=9.65), whereas good sleepers fell in the ‘no 
depression’ category (M=2.43). The percentages for each depression group (None, 
Mild, Moderate, Moderately Severe and Severe) are displayed in Table 4. The 
differences found between these groups were also significant (X2 (4, 291) = 59.93, 
p<.001, Cramer’s V=.45). 
 
Additionally, the mean total score of the GAD-7 was 6.59 with a range of 0-28 (Table 
4). This indicated that women experienced ‘mild anxiety severity’ on average (Spitzer 
et al., 2006). A significant difference was found between anxiety scores and good and 
poor sleep quality (U= 2031, p=<.001). On average, poor sleepers fell into the ‘mild 
anxiety’ category (M=7.27), whereas good sleepers fell into the ‘no anxiety’ band 
(M=2.40). Details for each anxiety group (None, Mild, Moderate, and Severe) can be 
seen in Table 4. Differences between groups were also found to be significant (X2 (3, 
292) = 22.72, p<.001, Cramers V=.28).  
 
Health Behaviours  
 
Details of the frequencies of each health behaviour are displayed in Table 4. The 
highest proportion of participants were ‘light drinkers’ (40.8%), ‘non-smokers’ (85%), 
and had ‘moderate’ physical activity levels (52.4%). As very few participants identified 
within a smoker group (‘heavy daily smokers’ [n= 15], ‘moderate daily smokers’ [n= 9], 
‘light daily smokers’ [n= 8], or ‘social smoker [n= 1]), a total ‘smoker’ group (n=33) was 
computed and used for further analyses. None of the examined health behaviours 
were significantly related to sleep quality. 
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Table 4.  
Bivariate analysis of the relationship between Sleep Quality and demographic variables, 
menopausal status, vasomotor symptoms, psychological health and health behaviours. 
 
 Overall 
(n= 292) 
 
N (%) or 
M ± SD 
Good (n= 40) 
(PSQI ≤ 5) 
 
N (%) or 
M ± SD 
Poor (n=252) 
(PSQI > 5) 
 
N (%) or 
M ± SD 
χ2 or t 
or U 
 
p 
Demographic variables      
Age 51.01(5.07) 51.65 ± 5.76 52.07± 4.96 -.48 .629 
Bed Sharing Status     .26 .878 
No 52(17.8) 6(15) 46 (18.3)   
Sometimes 34(11.6) 5 (12.5) 29(11.5)   
Yes 206(70.5) 29(72.5) 177(70.2)   
      
Child Status     8.75 .013 
No children 45(15.4) 8(20) 31(14.7)   
Child not living at home 78(26.7) 3(7.5) 75(29.8)   
Children living at home 169(57.9) 29(72.5) 140(55.6)   
      
Menopause status     7.99 .018 
Premenopause 57 (19.5) 14(35) 43(17.1)   
Perimenopause 95 (32.5) 13 (32.5) 82 (32.5)   
Postmenopause 140 (47.9) 13 (32.5) 127 (50.4)   
      
Vasomotor symptoms      
Total VMS severity score 2.45±1.79 0.93 ± 0.99 2.69 ± 1.764 -9.17 <.001 
Bothersome 246 (84.2) 22 (55) 224(88.9) 29.87 <.001 
Not Bothersome 46(15.8) 18 (45) 28 (11.1)   
      
Psychological Health      
Depression       
Total PHQ-9 Score 8.66±6.25 2.43 ± 3.26 9.65 ± 6.04 1265 <.001 
None 85(29.2) 32 (80) 53(21.1) 59.93 <.001 
Mild 93(32) 7(17.5) 86(34.3)   
Moderate 59(20.3) 0(0) 59(23.5)   
Moderately Severe 34(11.6) 1(2.5) 33(13.1)   
Severe 20(6.8) 0(0) 20 (8)   
      
Anxiety      
Total GAD-7 score 6.59 ± 3.58 2.40 ± 3.30 7.27 ± 5.35 2031 <.001 
None 122(41.9) 30(75) 92(36.5) 22.72 <.001 
Mild 91(31.2) 8(20) 83(32.9)   
Moderate 47(16.1) 2 (5) 45(17.9)   
Severe 32(11) 0(0) 32(12.7)   
      
Health behaviours      
Alcohol Consumption    6.73 .081 
Abstainer  90(30.8) 10(25) 80(31.7)   
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Light  119(40.8) 18(45) 101(40.1)   
Moderate 47(16.1) 3(7.5) 44(17.5)   
Heavy  36(13.3) 9(22.5) 27(10.7)   
      
Smoking Status    1.78 .183 
Non-Smoker 259(88.7) 33(82.5) 226 (89.7)   
Smoker 33(11.3) 7(17.5) 26(10.3)   
Light Daily 8(2.7)     
Moderate Daily 9(3.1)     
Heavy Daily 15(5.1)     
Social  1(0.3)     
      
Physical Activity    1.79 .410 
Low 100(34.2) 13(32.5) 87(34.5)   
Moderate 152(52.4) 19(47.5) 134(53.2)   
High 39(13.4) 8(20) 31(12.3)   
      
 
 
 
 
Strength of association between predictor variables and sleep quality. 
 
As parametric assumptions were violated, a non-parametric Spearman’s Rho was 
used to explore the relationship between the predictor variables (demographics, 
menopausal status, VMS, psychological health and health behaviours) and overall 
sleep quality (Table 5). 
 
Results showed a weak positive correlation between menopausal status and global 
PSQI (rs (292) = .16, p = .008), a moderative positive relationship between VMS 
severity scores and global PSQI (rs (292) = .49, p = <.001), and a strong positive 
relationship between both GAD-7 (rs (292) = .61,  p = <.001) and PHQ-9 (rs (291) = 
.66, p = <.001), and Global PSQI. However, none of the examined health behaviours 
(alcohol consumption, cigarette smoking status, physical activity level) or demographic 
variables (age, bed partner status, child status) significantly correlated with Global 
PSQI scores. 
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Table 5.  
Spearman’s Rho correlation for all variables. 
 
Scale 1 2 3 4 5 6 7 8 9 10 11 
1.Global PSQI             
2. Menopausal status .16**           
3. VMS severity .49** .16**          
4. PHQ-9 .66* -.01 .39**         
5. GAD-7 .61** .00 .38** .69**        
6. Alcohol consumption -.09 .08 -.05 -.18** -.06       
7. Cigarette Smoking status -.04 .01 .04 -.07 -.05 .01      
8. Physical Activity Level -.08 -.07 .01 -.20** -.14* .18** .06     
9. Age .07 .71** .02 -.10 -.11 .07 .05 -.00    
10. Bed partner status -.14 -.05 -.10 -.19** -.11 .04 .01 .10 -.01   
11. Child status .05 -.21** .13* .08 .13* -.09 .06 -.01 -.24** .07  
Note.  
**= significant at p<.001 level 
*= significant at p<.05 level 
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Predictive contribution of menopausal status, vasomotor symptoms, 
psychological health, health behaviours and demographics to sleep quality. 
 
A multiple linear regression using an enter approach was conducted to examine the 
contribution of the aforementioned predictor variables to sleep quality.  Parametric 
assumptions of homoscedasticity, collinearity, and independence (Durbin Watson 
value = 2.01) were met. However, normality was violated, due to skewed PHQ-9 and 
GAD-7 scores. Data for both variables were transformed by square rooting. Only 
distribution of the GAD-7 scores improved, thus the original data for PHQ-9 was 
utilised for analysis. Results regarding this variable should be interpreted with caution. 
 
The results for the multiple regression can be seen in Table 6. Overall, the regression 
model was found to be significant, explaining 54.9% of variance in Global PSQI scores 
(F (10,280) = 34.13, p<.001, R2 =.54). This demonstrates that collectively menopausal 
status, VMS, depression, anxiety, alcohol consumption, cigarette smoking status, 
physical activity level, age, bed partner status, and child status predict sleep quality. 
However, only 3 predictors; VMS severity (β = .258, p=<.001), PHQ-9 (β = .369, 
p=<.001) and GAD-7 (β = .233, p=<.001), were statistically significant independent 
predictors. This illustrates that only VMS, depression and anxiety are significantly 
associated with sleep quality. Beta values indicated that as bothersome VMS, 
depressive symptoms and anxiety symptoms increase, sleep quality scores increase 
(indicating poorer sleep quality). Additionally, of these three variables, the PHQ-9 
made the largest unique contribution (β = .369). This suggests that depression relates 
to sleep quality the greatest when the variance explained by other variables is 
controlled for.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6. Summary of linear multiple regression model for variables 
predicting sleep quality (Global PSQI)  
 
Predictors B SE β t p 
Menopausal Status .385 .326 .069 1.182 .238 
VMS severity .618 .109 .258 5.667 <.001 
PHQ-9 .271 .047 .369 5.829 <.001 
GAD-7 .825 .235 .233 3.503 <.001 
Alcohol Consumption -.030 .184 -.007 -.161 .872 
Cigarette Smoking Status .043 .547 .003 .078 .938 
Physical Activity Level .037 .275 .006 .135 .893 
Age .055 .049 .066 1.137 .257 
Bed Partner Status .112 .227 .020 .495 .621 
Child Status -.189 .243 -.033 -.779 .437 
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Discussion 
 
In the present research, an overwhelming 86.3% of midlife women reported poor sleep 
quality. This prevalence is greater than previously documented, whereby 40-60% of 
midlife women are found to have sleep impairments (Kravitz et al., 2008; Ağan et al., 
2015). Findings could suggest that sleep problems within midlife are rising over time, 
or perhaps reflect that British women (presumed to be the majority population within 
this sample) have greater sleep difficulties compared to other populations used within 
previous research (e.g. Turkish women - Ağan et al., 2015). Nonetheless, findings 
emphasise a greater need to understand what is contributing to poor sleep. In light of 
this, the present study aimed to identify risk factors of poor sleep quality. Menopausal 
status, VMS, psychological health (depression and anxiety) and health behaviours 
(cigarette smoking, physical activity and alcohol consumption) were examined as 
correlates and predictors of sleep quality. 
 
Menopause itself was found to not be inevitably associated with poor sleep quality. 
The present study demonstrated that menopausal status did not predict sleep quality. 
Such findings have been confirmed by some previous research, but not all. Pien et 
al.’s (2008) 8-year longitudinal study, for example; found women’s sleep quality did 
not differ through the menopause transition. Additionally, Blümel et al. (2012) study of 
women from 11 American states, concluded that the influence of menopause on sleep 
disturbance was modest. Conversely, research often demonstrates that menopause 
significantly relates to poor sleep (Xu & Lang, 2014; Lampio et al., 2017).  Kravitz et 
al. (2003) found peri and post-menopausal women had greater sleep difficulties (50%) 
than premenopausal (30%). Likewise, the present study illustrated that women in peri 
(32.5%) and post-menopause (50.4%) had poorer sleep quality than premenopause 
(17.1%). Importantly, however, this relationship became nonsignificant when other 
variables were controlled. Other studies also demonstrate that menopause relates to 
sleep in unadjusted conditions, but not controlled. Both Chung and Tang (2006) and 
Xu et al. (2016) found at bivariate analysis that post and peri-menopausal had 
significantly greater sleep difficulties than premenopausal (22-25% vs 7% and 47-49% 
vs 30% respectively). However, in both studies, regression analyses (controlling for 
other variables) identified menopause had no strength in predicting sleep quality. 
Thus, the present results are consistent with previous research. Arguing that 
menopause per se correlates with poorer sleep; however, does not predict sleep 
quality when other factors are considered.  
 
Bothersome VMS were found to be strongly associated with poor sleep quality. 
Women’s symptom scores were found to be significantly higher for poor sleepers than 
good (VMS severity score: 2.69 vs 0.93). Previous research draws similar conclusions. 
Kravitz et al.’s (2003) study of 12,600 women, found those with present VMS had 
greater sleep difficulties. Likewise, in subsequent research, Kravitz et al. (2008) 
reported that those with severe symptoms (>6 days in a 2-week period) were more 
likely to report poorer sleep. However, caution needs to be taken when comparing the 
present findings to previous research. The aforementioned literature only considers 
the presence/frequency of VMS, whereas this study measured how bothersome 
women perceived symptoms to be. Thurston et al. (2008) proposed that understanding 
the bothersomeness of symptoms is important, as symptoms could occur without 
interference on sleep. In the present study, poor sleep was significantly predicted by 
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bothersome VMS. A greater frequency of women with poor sleep reported bothersome 
symptoms (88.9%) compared to not-bothersome (11%). This supports research by Xu 
et al. (2012), who reported bothersome symptoms, but not symptoms without bother, 
predicted sleep disturbance. Interestingly, the prevalence of bothersome symptoms in 
their study was much less than the present (30% vs 84.2%). An explanation for this 
discrepancy could be that the current sample was skewed towards postmenopausal 
women (47.9%). Hardy and Kuh (2002) observed that VMS increased in 
postmenopausal women, relative to women in other menopausal stages. Thus, the 
effects on sleep may be overestimated within the present study. Nonetheless, findings 
add to the limited literature that attempts to disentangle the relationship between 
perceived bothersomeness of VMS and sleep. 
 
In addition, the present study found both psychological health variables, depression 
and anxiety, to be independent risk factors of poor sleep quality. In regard to 
depression, women reporting poor sleep had greater depression severity scores 
compared to those reporting good sleep (PHQ-9 score; 9.65 vs 2.43).  This finding is 
consistent with previous research that reports robust associations with depression and 
poor sleep. Tom et al. (2010) found greater prevalence of depression in women with 
troubled sleep compared to less troubled sleep (40% vs 27%). Similarly, Xu et al. 
(2016) found depression to be 2-times greater in poor sleepers than good (44% vs 
23%). Research also suggests that depression makes the strongest predictive 
contribution to poor sleep quality, relative to other variables investigated. For example, 
Hsu and Lin (2005) investigated occupational status, chronic disease, menopausal 
status, number of medical illnesses, menopausal symptoms, age and depression as 
predictors of sleep quality. Depression was found to be the major predictor of sleep 
quality, accounting for 33% of the variance. Likewise, the present study found that out 
of all significant predictor variables, depression made the largest unique contribution 
to sleep quality. Findings indicated that as depression severity increased, women’s 
subjective sleep quality ratings decreased. Interestingly, a greater proportion of 
women with poor sleep reported mild depression (34.3%), compared to severe (8%). 
This could support Buysse et al.’s (2008) finding, that adverse effects on sleep are 
found when individuals report only mild psychological symptoms. However, a better 
explanation could be that the present sample overall had more women with mild (32%) 
than severe depression (6.8%). Unfortunately, other studies are not directly 
comparable to the present research as they only measure depression dichotomously 
(‘depression’ or ‘no depression’). Future research examining sleep quality should 
therefore consider depression severity and not presume only the presence of 
symptoms predict poor sleep quality. 
 
Moreover, anxiety was found to be a significant predictor of sleep quality. Women 
reporting poor sleep had significantly higher anxiety severity scores than good 
sleepers (GAD-7 score: 7.27 vs 2.40). Likewise, research from Freedman and Roehrs 
(2007) found higher anxiety scores predicted low subjective sleep quality in midlife 
women. More specifically, Xu et al (2016) identified that the prevalence of anxiety was 
3-times greater in poor sleepers, compared to good sleepers (43% vs 13%). These 
findings, alongside the present study, suggest that anxiety has an important 
relationship with the sleep of midlife women, which may not be surprising when 
considering the overlap between anxiety and insomnia (American Psychiatric 
Association, 2013). Yet, the role between anxiety and sleep in this age group is not 
well understood. One proposed reason for the association between sleep and anxiety 
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in this age group is that midlife is a time of multiple changes, including children leaving 
the family home (‘empty nest’ phenomenon) and interpersonal relationships failing 
(e.g. divorce) (Wang, Shu, Dong, Luo & Hao, 2013; Kuh, Hardy, Rodgers & 
Wadsworth, 2002). This study examined the effects on sleep quality of both children 
not living at home, and relationship status. No significant relationships were found. In 
fact, poor sleep was found to occur more often when children were living at home. 
Therefore, conclusions can be made that although psychological symptoms predict 
poor sleep quality, the mechanisms underlying this is not clearly understood. 
Nonetheless, this study makes significant contributions to the limited research 
findings, emphasising the need for further investigation within the future. 
 
In contrast, all health behaviours (alcohol, smoking and physical activity) were found 
to not be associated with poor sleep quality. This contradicts the limited existing 
research that suggests risk behaviours increase sleep difficulties (Woods & Mitchell, 
2010; Gold et al., 2000; NSF, 2013; Ağan et al., 2015).  Disparity in findings could be 
due to the different methods used to obtain health behaviours in the present and 
previous research. For example, significant associations between health behaviours 
and sleep quality are commonly found when using interviews to gather data (Gold et 
al., 2000; Ağan et al., 2015). Whereas, when questionnaires are used (like the present 
study), non-significant relationships between health behaviour and sleep are reported 
(Tom et al.,2010). This could suggest that non-significant findings may be attributed 
to the way in which data was collected in this study. One reason for this may be that 
questionnaires (as opposed to interviews) promote misreporting, as participants 
cannot confirm any ambiguity. But equally, significant findings from interviews may be 
the result of bias - as interviewers can lead questions to obtain answers that support 
the desired outcome. Thus, one method is not more desirable than the other. However, 
a more likely reason for the non-significant relationship between health behaviours 
and sleep quality within the present study, is that only small numbers of women 
actually engaged in unhealthy behaviours. For example, only 33 women smoked; 
whereas 259 didn’t. This controversially suggests that midlife women may not engage 
in greater risk behaviours - as the ONS (2018) suggested. Perhaps midlife women are 
more health conscious than previously thought, which could be why negative effects 
on sleep were not found. 
 
Furthermore, findings of the current study need to be considered in light of a number 
of limitations. Firstly, a cross-sectional design was used; meaning that a causal 
relationship between VMS, depression, anxiety and sleep quality could not be 
determined. Previously, research has acknowledged that the relationship between 
these variables is complex. For example, psychological symptoms can both precede 
the onset and occur as a consequence of poor sleep quality. Sivertson et al. (2009) 
found that depression (without insomnia) or insomnia (without depression) at baseline, 
predicted insomnia or depression at the follow up respectively. Additionally, the 
independence of variables is unclear. The domino hypothesis (Campbell & Whitehead, 
1997) proposes that sleep disturbances mediate a relationship between VMS and 
psychological variables. Simply, VMS disturb sleep, and sleep causes psychological 
symptoms. In the present study vasomotor symptoms were found to positively 
correlate with both psychological health variables. However, due to the design of this 
study the complex bidirectionality of relationships could not be captured. To 
understand these relationships in future research, a longitudinal design would be 
required. 
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Moreover, subjective sleep was the only outcome studied. Discrepancies between 
subjective and objective sleep in midlife women has been well documented. Young, 
Rabago, Zgierska, Austin, and Laurel (2003) illustrated this in their examination of 
menopausal status and sleep quality. In subjective sleep quality measures, 
menopausal women had poorer sleep than premenopausal. However, objective 
measures (using PSG), found that menopausal women had significantly better sleep 
quality (i.e. longer sleep duration) than premenopausal. This highlights that 
questionnaire findings, like the present, may not be an accurate reflection of women’s 
objective sleep quality. To reinforce significant findings, future research should include 
objective measures to validate the subjective information provided by participants. 
Nonetheless, subjective studies still remain important; after all, one’s own perception 
of health is what prompts them to seek medical help and guides the direction of 
medical interventions (Mishra & Kuh, 2006). 
 
Despite some limitations, the present study has much strength, such as its large 
sample size, use of standardised measures for key variables, novel findings and 
directions for future research. Additionally, findings provide promising implications for 
guiding development of future interventions. By understanding that VMS and 
psychological health significantly contribute to poor sleep within midlife women, 
targeting these symptoms may improve sleep and reduce the related consequences 
(e.g. early mortality - Cappuccio et al., 2010). An existing sleep intervention, hormone 
replacement therapy (HRT), effectively reduces both physical and psychological 
symptoms of menopause (NHS, 2016). Pinkerton, Abraham, Bushmakin, Cappelleri 
and Komm (2016) found HRT reduced the frequency of VMS from >7 to 5 per day. 
Likewise, Boyle and Murrihy (2001) found HRT significantly reduced psychological 
symptoms compared with controls. Both studies also reported significant reductions 
in sleep problems. Therefore, utilising HRT to target the symptoms may be more 
effective than treating sleep directly. Currently, sleep problems in midlife women are 
widely treated with sedatives that do not target all predictors of sleep found within this 
study (Hall, Kline & Nowakowski, 2015). This may be an important reason why the 
prevalence of poor sleep in midlife women remains extremely high.  
 
In summary, this study identified that VMS, anxiety and depression were unique 
predictors of poor sleep quality in midlife women. The latter was found to be the 
strongest contributor. Menopausal status did correlate with poor sleep quality, 
however, was not an independent predictor when other factors were controlled. This 
proposes that menopause symptoms (vasomotor and psychological) may mediate the 
effect of menopause on sleep. Health behaviours were found to not be related to poor 
sleep quality. Collectively, findings demonstrate what may predominantly be 
contributing to the poor sleep described by midlife women. In understanding this, 
recommendations can be given to clinicians to treat the active symptoms and 
effectively reduce sleep difficulties and their detrimental consequences. However, 
before this can be done with confidence, further research is required and should 
expand on the measures and design used within this study. Nonetheless, the present 
study contributes to a limited body of research and proposes factors that may play a 
significant role in the high rates of sleep difficulties reported by midlife women. 
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